Related Experiment Video
Updated: Aug 11, 2026
An “All-laser” Endothelial Transplant
Published on: July 6, 2015
Holmium:YAG laser system for transmyocardial revascularization
1Department of Cardiothoracic Surgery, Indianapolis, IN 46290, USA. kallen2340@aol.com
Transmyocardial revascularization using the holmium: yttrium-aluminum-garnet (Ho:YAG) laser is an option for severe angina. Further research into enhancing outcomes with this laser therapy is recommended.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Procedures
- Laser Technology in Medicine
Background:
- Debilitating angina often results from diffuse coronary artery disease.
- Conventional treatments may not be suitable for all patients.
- Transmyocardial revascularization (TMR) offers an alternative surgical option.
Purpose of the Study:
- To review the clinical science of Ho:YAG laser TMR.
- To emphasize randomized controlled trials in TMR patient groups.
- To discuss the potential for enhanced outcomes.
Main Methods:
- Utilizing the US FDA-approved holmium: yttrium-aluminum-garnet (Ho:YAG) laser system.
- Focusing on randomized controlled trials.
- Reviewing clinical data for TMR efficacy.
Main Results:
- Ho:YAG laser TMR is a viable surgical option.
- Evidence from randomized controlled trials supports its use.
- Further research can optimize patient outcomes.
Conclusions:
- Ho:YAG laser transmyocardial revascularization is a valuable treatment for specific angina patients.
- Increased utilization is warranted.
- Continued research into adjunctive therapies is crucial for improving results.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
06:04Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018